695 related articles for article (PubMed ID: 24286179)
21. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
22. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
[TBL] [Abstract][Full Text] [Related]
23. Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Lagarde I; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):95-9. PubMed ID: 1878248
[TBL] [Abstract][Full Text] [Related]
24. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
25. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions.
Pireddu R; Sinico C; Ennas G; Schlich M; Valenti D; Murgia S; Marongiu F; Fadda AM; Lai F
Colloids Surf B Biointerfaces; 2018 Feb; 162():8-15. PubMed ID: 29132043
[TBL] [Abstract][Full Text] [Related]
26. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models.
Praça FSG; Medina WSG; Eloy JO; Petrilli R; Campos PM; Ascenso A; Bentley MVLB
Eur J Pharm Sci; 2018 Jan; 111():121-132. PubMed ID: 28951120
[TBL] [Abstract][Full Text] [Related]
28. Topical antifungal bigels: Formulation, characterization and evaluation.
Mazurkeviciute A; Ramanauskiene K; Ivaskiene M; Grigonis A; Briedis V
Acta Pharm; 2018 Jun; 68(2):223-233. PubMed ID: 29702483
[TBL] [Abstract][Full Text] [Related]
29. Trans-resveratrol and beta-carotene from sunscreens penetrate viable skin layers and reduce cutaneous penetration of UV-filters.
Freitas JV; Praça FS; Bentley MV; Gaspar LR
Int J Pharm; 2015 Apr; 484(1-2):131-7. PubMed ID: 25724133
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib.
Quiñones OG; Mata dos Santos HA; Kibwila DM; Leitão A; dos Santos Pyrrho A; Pádula Md; Rosas EC; Lara MG; Pierre MB
Drug Dev Ind Pharm; 2014 Sep; 40(9):1180-9. PubMed ID: 23826859
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
32. Impacts of chemical enhancers on skin permeation and deposition of terbinafine.
Erdal MS; Peköz AY; Aksu B; Araman A
Pharm Dev Technol; 2014 Aug; 19(5):565-70. PubMed ID: 23841559
[TBL] [Abstract][Full Text] [Related]
33. Applying response surface methodology to optimize nimesulide permeation from topical formulation.
Shahzad Y; Afreen U; Nisar Hussain Shah S; Hussain T
Pharm Dev Technol; 2013; 18(6):1391-8. PubMed ID: 22994526
[TBL] [Abstract][Full Text] [Related]
34. New easy handling and sampling device for bioavailability screening of topical formulations.
Salmon D; Gilbert E; Gioia B; Haftek M; Pivot C; Verrier B; Pirot F
Eur J Dermatol; 2015 Apr; 25 Suppl 1():23-9. PubMed ID: 26083671
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model.
Caon T; Costa AC; de Oliveira MA; Micke GA; Simões CM
Int J Pharm; 2010 May; 391(1-2):1-6. PubMed ID: 20156540
[TBL] [Abstract][Full Text] [Related]
36. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations.
Herai H; Gratieri T; Thomazine JA; Bentley MV; Lopez RF
Int J Pharm; 2007 Feb; 329(1-2):88-93. PubMed ID: 17027205
[TBL] [Abstract][Full Text] [Related]
38. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
[TBL] [Abstract][Full Text] [Related]
39. Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy.
Mélot M; Pudney PD; Williamson AM; Caspers PJ; Van Der Pol A; Puppels GJ
J Control Release; 2009 Aug; 138(1):32-9. PubMed ID: 19401210
[TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
